ongoing research in gastric cancer; antiangiogenic therapy upfront and immunotherapy
Published 7 years ago • 596 plays • Length 10:16Download video MP4
Download video MP3
Similar videos
-
7:26
is frontline io therapy appropriate in gastric cancer?
-
1:33
dr. fuchs discusses immunotherapy in gastric cancer
-
1:17
dr. arkenau on the potential of immunotherapy in gastric cancer
-
1:07
dr. smaglo on the future of immunotherapy in gastric cancer
-
6:16
upfront antiangiogenic therapy in advanced ovarian cancer
-
7:00
interpretation of data on immunotherapy use in gastric cancer
-
0:44
dr. yoon on immunotherapy in gastric cancer
-
5:17
msi testing’s impact on immunotherapy in gastric cancers
-
5:40
patient selection for immunotherapy in gastric cancer
-
2:07
dr. janjigian on immunotherapy combinations in gastric cancer
-
0:31
role of immunotherapy in gastric cancers
-
6:19
immunotherapy in advanced/metastatic gastric/gej cancers
-
1:47
dr. janjigian on immunotherapy in esophageal and gastric cancer
-
0:48
current and future directions in gastric cancer research
-
1:14
dr. ahn on the role of immunotherapy in treating patients with gastric/gastroesophageal cancers
-
3:35
switch maintenance in gastric cancer: results of javelin gastric 100
-
5:29
resistance to antiangiogenic therapy in lung cancer
-
4:12
metastatic gastric cancer: factors in selecting frontline therapy
-
7:01
antiangiogenesis in gastric/gej cancers: a global view